Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.
van Nassau SC, Bond MJ, Scheerman I, van Breeschoten J, Kessels R, Valkenburg-van Iersel LB, Verheul HM, Buffart TE, Mekenkamp LJ, Lemmens VE, Koopman M, Bol GM; EXCITE (From Clinical Trial to Bedside: Triplet Chemotherapy in Metastatic Colorectal Cancer) Study Group. van Nassau SC, et al. Among authors: koopman m. JAMA Netw Open. 2021 Sep 1;4(9):e2124766. doi: 10.1001/jamanetworkopen.2021.24766. JAMA Netw Open. 2021. PMID: 34505885 Free PMC article.
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.
Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJ, Schrama JG, Erdkamp FL, Vos AH, van Groeningen CJ, Sinnige HA, Richel DJ, Voest EE, Dijkstra JR, Vink-Börger ME, Antonini NF, Mol L, van Krieken JH, Dalesio O, Punt CJ. Tol J, et al. Among authors: koopman m. N Engl J Med. 2009 Feb 5;360(6):563-72. doi: 10.1056/NEJMoa0808268. N Engl J Med. 2009. PMID: 19196673 Free article. Clinical Trial.
Chemotherapy, which drugs and when.
Koopman M, Punt CJ. Koopman M, et al. Eur J Cancer. 2009 Sep;45 Suppl 1:50-6. doi: 10.1016/S0959-8049(09)70016-4. Eur J Cancer. 2009. PMID: 19775604 Review. No abstract available.
Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.
Mekenkamp LJ, Heesterbeek KJ, Koopman M, Tol J, Teerenstra S, Venderbosch S, Punt CJ, Nagtegaal ID. Mekenkamp LJ, et al. Among authors: koopman m. Eur J Cancer. 2012 Mar;48(4):501-9. doi: 10.1016/j.ejca.2011.12.004. Epub 2012 Jan 4. Eur J Cancer. 2012. PMID: 22226571
Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: a retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG).
Venderbosch S, Doornebal J, Teerenstra S, Lemmens W, Punt CJ, Koopman M. Venderbosch S, et al. Among authors: koopman m. Acta Oncol. 2012 Sep;51(7):831-9. doi: 10.3109/0284186X.2012.699193. Epub 2012 Jul 16. Acta Oncol. 2012. PMID: 22794910
Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.
Mekenkamp LJ, Tol J, Dijkstra JR, de Krijger I, Vink-Börger ME, van Vliet S, Teerenstra S, Kamping E, Verwiel E, Koopman M, Meijer GA, van Krieken JH, Kuiper R, Punt CJ, Nagtegaal ID. Mekenkamp LJ, et al. Among authors: koopman m. BMC Cancer. 2012 Jul 17;12:292. doi: 10.1186/1471-2407-12-292. BMC Cancer. 2012. PMID: 22804917 Free PMC article.
456 results